Live Breaking News & Updates on Maggie fick

Stay informed with the latest breaking news from Maggie fick on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Maggie fick and stay connected to the pulse of your community

AstraZeneca trounces first-quarter estimates as resilient demand fuels growth

(Reuters) -AstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by demand for its blockbuster drugs and steady sales from partnered medicines, and sending its shares up over 5%. CEO Pascal Soriot has rebuilt the company's pipeline of new drugs since taking the helm more than a decade ago, to make blockbusters such as lung cancer drug Tagrisso, leukaemia drug Calquence and Farxiga for diabetes. Combined revenue from partnered medicines, such as breast cancer therapy Enhertu with Daiichi Sankyo and asthma medicine Tezspire with Amgen, jumped more than 60% in the quarter, bolstering overall growth.

Bengaluru , Karnataka , India , London , City-of , United-kingdom , Sweden , Pascal-soriot , Subhranshu-sahu , Daiichi-sankyo , William-mallard , Eva-mathews

German industry sceptical of China's vow to treat foreign firms equally

A fresh pledge by
Beijing to treat foreign companies like domestic rivals drew a
cool response from one of its biggest trading partners, Germany,
where industries called for concrete actions rather...

Berlin , Germany , China , London , City-of , United-kingdom , Frankfurt , Brandenburg , United-states , Beijing , Chinese , American

German Industry Sceptical of China's Vow to Treat Foreign Firms Equally

German Industry Sceptical of China's Vow to Treat Foreign Firms Equally
usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.

China , Beijing , Berlin , Germany , United-states , London , City-of , United-kingdom , Frankfurt , Brandenburg , American , German

German industry sceptical of China's vow to treat foreign firms equally | WSAU News/Talk 550 AM · 99.9 FM

By Christoph Steitz and Rene Wagner FRANKFURT/BERLIN (Reuters) - A fresh pledge by Beijing to treat foreign companies like domestic rivals drew a cool response from one of its biggest trading partners, Germany, where industries called for concrete ...

Berlin , Germany , Frankfurt , Brandenburg , China , Beijing , United-states , London , City-of , United-kingdom , German , American

World Health Organization: Novo Nordisk tackles harm from Ozempic fakes with global authorities, ET HealthWorld

The World Health Organization has said global shortages of these drugs is linked to rising reports of suspected counterfeits. Last week, U.S. FDA head Robert Califf said there were likely more cases of online sales of fake obesity drugs than reported.

Serbia , Switzerland , Austria , Iraq , France , Belgium , United-kingdom , Lebanon , Denmark , United-states , London , City-of

Astrazeneca says Catalent deal shows importance of in-house capacity

Astrazeneca on Thursday said the sale of contract drugmaker Catalent to the parent of Novo Nordisk this week demonstrates the importance of building an independent supply chain....

Bengaluru , Karnataka , India , London , City-of , United-kingdom , Pascal-soriot , David-goodman , Maggie-fick , Eva-mathews , Novo-nordisk , Astrazeneca

Astrazeneca says Catalent deal shows need for in-house capacity By Reuters

Astrazeneca says Catalent deal shows need for in-house capacity By Reuters
investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.

Maryland , United-states , London , City-of , United-kingdom , Maggie-fick , Eva-mathews , Pascal-soriot , Reuters , Novo-holdings-on , Astrazeneca , Novo-nordisk

Novo Nordisk's Parent to Buy Catalent for $11.5 Billion to Boost Wegovy Supply

Novo Nordisk notched a win on Monday in its race to boost output of its popular obesity drug Wegovy, with its parent company announcing it was buying Catalent, a key...

Copenhagen , Køavn- , Denmark , Anagni , Lazio , Italy , Indiana , United-states , Bengaluru , Karnataka , India , London

Roche forecasts return to growth in 2024 as it overcomes drop in COVID sales

Roche said on Thursday that 2024 would see a return to sales growth as it is overcoming a slump in demand for its COVID-19 products and the sales decline of a trio of established cancer drugs is...

Switzerland , Swiss , Ludwig-burger , Thomas-schinecker , Maggie-fick , Christopher-cushing , Markets ,

Roche sees pick up in growth as it overcomes drop in COVID sales

LONDON/FRANKFURT (Reuters) -Roche forecast a pick up in sales growth this year as it overcomes a slump in demand for its COVID-19 products and a decline in sales of a trio of established cancer drugs abates. Sales in 2023 rose 1% to 58.7 billion Swiss francs ($68 billion), slightly below analysts' average estimate of closer to 60 billion francs, according to LSEG data. CEO Thomas Schinecker told reporters it was a "significant achievement" that the company increased sales despite the sharp drop in demand for its COVID therapy and diagnostics kits.

Switzerland , Frankfurt , Brandenburg , Germany , Swiss , Ludwig-burger , Thomas-schinecker , Michael-perry , Mark-potter , Maggie-fick , Reuters , Carmot-therapeutics